Here are the top stories of 2023
Here are the stories that captured your attention in 2023 from NPR.org and across the NPR Network.
Stay updated with breaking news from Published August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Here are the stories that captured your attention in 2023 from NPR.org and across the NPR Network.
Here are the stories that captured your attention in 2023 from NPR.org and across the NPR Network.
14.10.2023 - Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) was approved by the U.S. Food and Drug Administration (FDA) for the adjuvant treatment of adult and pediatric patients 12 years and older with completely resected stage IIB or ...
In the Phase 3 CheckMate -76K trial, Opdivo demonstrated a statistically significant improvement in recurrence-free survival compared to placebo1 CheckMate -76K marks the fifth Opdivo-based...